Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.

Source:http://linkedlifedata.com/resource/pubmed/id/21239398

Download in:

View as

Triples

General Info

PMID
21239398